# MiniMed's Product Cycle Hides Split-Off Hangover

> MiniMed's split-off obscures product-cycle progress despite strong Q1 growth.
- Title: MiniMed's Product Cycle Hides Split-Off Hangover | Shortify
- Summary: MiniMed's split-off obscures product-cycle progress despite strong Q1 growth. MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S.
- Keywords: minimed, q1 organic growth, u.s. pump volumes, recurring revenue, product cycle, split-off, Seekingalpha
- URL: https://shortify.news/Seekingalpha/minimeds-product-cycle-hides-split-off-hangover
- Source: Seekingalpha — https://seekingalpha.com/article/4969480-minimed-the-split-off-hangover-is-hiding-a-full-stack-product-cycle
- Published: 2026-11-18T10:02:21+00:00
- Read time: 1 min
- Topics: minimed, q1 organic growth, u.s. pump volumes, recurring revenue, product cycle, split-off, money, business
## MiniMed Group
MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20%.
## Product Cycle Progress
Flex, the Fit patch pump, and Vivera could complete MiniMed's portfolio by late 2027 despite regulatory, competitive, and separation risks.
## Share Taker Shift
MiniMed is priced at 1.43x forward EV/sales with potential recovery from easing split-off supply and improved cash conversion.
## Key takeaway

MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20% as it shifts from share donor to share taker.

---

Summary: Shortify — https://shortify.news/Seekingalpha/minimeds-product-cycle-hides-split-off-hangover
Reporting: Seekingalpha — https://seekingalpha.com/article/4969480-minimed-the-split-off-hangover-is-hiding-a-full-stack-product-cycle

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.